---
figid: PMC12113870__molecules-30-02203-g002
figtitle: Hesperidin action on the NFKB signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12113870
filename: molecules-30-02203-g002.jpg
figlink: /pmc/articles/PMC12113870/figure/F2/
number: F2
caption: 'Mechanism of hesperidin action on the NF-κB signaling pathway. Hesperidin
  inhibits the activation of the NF-κB pathway by blocking surface receptors such
  as TLR4, IL-1R, and TNFR1, leading to the inhibition of the IKK complex and preventing
  the degradation of the inhibitor IκBα. As a result, the transcription factor NF-κB
  remains inactive in the cytoplasm, reducing the expression of pro-inflammatory genes
  (e.g., IL-6, TNF-α, IL-1β). Additionally, hesperidin neutralizes reactive oxygen
  species (ROS), reducing oxidative stress, which can also activate NF-κB. The overall
  effect of hesperidin is the reduction of inflammatory responses and oxidative stress.
  Abbreviations: A20—TNFAIP3 ubiquitin-editing enzyme; CAT—catalase; CIAP1/2—cellular
  inhibitor of apoptosis protein 1 and 2; COX—cyclooxygenase; COX-2—cyclooxygenase-2;
  CYLD—cylindromatosis lysine 63 deubiquitinase; GPx—glutathione peroxidase; H2O2—hydrogen
  peroxide; IKKα—IκB kinase alpha; IKKβ—IκB kinase beta; IL-1R—interleukin-1 receptor;
  IL-6—interleukin-6; IRAK1/4—interleukin-1 receptor-associated kinase 1 and 4; LOX—lipoxygenase;
  LUBAC—linear ubiquitin chain assembly complex; MyD88—myeloid differentiation primary
  response 88; NEMO—NF-κB essential modulator; NF-κB—nuclear factor kappa-light-chain-enhancer
  of activated B cells; NOX—NADPH oxidase; •O2−—superoxide anion radical; •OH—hydroxyl
  radical; RIPK1—receptor-interacting serine/threonine-protein kinase 1; SOD—superoxide
  dismutase; SPATA2—spermatogenesis-associated protein 2; TAB2/3—TAK1-binding proteins
  2 and 3; TAK1—transforming growth factor-β-activated kinase 1; TLR4—toll-like receptor
  4; TNF-α—tumor necrosis factor alpha; TNFR1—tumor necrosis factor receptor 1; TRADD—TNFR1-associated
  death domain protein; TRAF2/5—TNF receptor-associated factor 2 and 5; TRAF6—TNF
  receptor-associated factor 6; XDH—xanthine dehydrogenase. Created in BioRender.
  Bijak, M. (2025) https://BioRender.com/99h60kh, accessed on 15 May 2025 [25,29,30]'
papertitle: Flavanones as Modulators of Gut Microbiota and Cognitive Function
reftext: Natalia Cichon, et al. Molecules. 2025 May;30(10).
year: '2025'
doi: 10.3390/molecules30102203
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: flavanones | naringenin | hesperidin | gut–brain axis | microbiota | cognitive
  health
automl_pathway: 0.954379
figid_alias: PMC12113870__F2
figtype: Figure
redirect_from: /figures/PMC12113870__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12113870__molecules-30-02203-g002.html
  '@type': Dataset
  description: 'Mechanism of hesperidin action on the NF-κB signaling pathway. Hesperidin
    inhibits the activation of the NF-κB pathway by blocking surface receptors such
    as TLR4, IL-1R, and TNFR1, leading to the inhibition of the IKK complex and preventing
    the degradation of the inhibitor IκBα. As a result, the transcription factor NF-κB
    remains inactive in the cytoplasm, reducing the expression of pro-inflammatory
    genes (e.g., IL-6, TNF-α, IL-1β). Additionally, hesperidin neutralizes reactive
    oxygen species (ROS), reducing oxidative stress, which can also activate NF-κB.
    The overall effect of hesperidin is the reduction of inflammatory responses and
    oxidative stress. Abbreviations: A20—TNFAIP3 ubiquitin-editing enzyme; CAT—catalase;
    CIAP1/2—cellular inhibitor of apoptosis protein 1 and 2; COX—cyclooxygenase; COX-2—cyclooxygenase-2;
    CYLD—cylindromatosis lysine 63 deubiquitinase; GPx—glutathione peroxidase; H2O2—hydrogen
    peroxide; IKKα—IκB kinase alpha; IKKβ—IκB kinase beta; IL-1R—interleukin-1 receptor;
    IL-6—interleukin-6; IRAK1/4—interleukin-1 receptor-associated kinase 1 and 4;
    LOX—lipoxygenase; LUBAC—linear ubiquitin chain assembly complex; MyD88—myeloid
    differentiation primary response 88; NEMO—NF-κB essential modulator; NF-κB—nuclear
    factor kappa-light-chain-enhancer of activated B cells; NOX—NADPH oxidase; •O2−—superoxide
    anion radical; •OH—hydroxyl radical; RIPK1—receptor-interacting serine/threonine-protein
    kinase 1; SOD—superoxide dismutase; SPATA2—spermatogenesis-associated protein
    2; TAB2/3—TAK1-binding proteins 2 and 3; TAK1—transforming growth factor-β-activated
    kinase 1; TLR4—toll-like receptor 4; TNF-α—tumor necrosis factor alpha; TNFR1—tumor
    necrosis factor receptor 1; TRADD—TNFR1-associated death domain protein; TRAF2/5—TNF
    receptor-associated factor 2 and 5; TRAF6—TNF receptor-associated factor 6; XDH—xanthine
    dehydrogenase. Created in BioRender. Bijak, M. (2025) https://BioRender.com/99h60kh,
    accessed on 15 May 2025 [25,29,30]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - IL1R1
  - RNASE9
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - IKBKG
  - RBM8A
  - TNFRSF1A
  - CYLD
  - TRADD
  - TRA
  - THRA
  - TRAC
  - CAP1
  - PRSS8
  - CAP2
  - SERPINB8
  - TMPRSS4
  - IL6
  - COX2
  - PTGS2
  - MTCO2P12
  - TNF
  - TAB2
  - TAB3
  - OTULIN
  - SOD1
  - SOD2
  - SOD3
  - CAT
  - CRAT
  - GLYAT
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - XDH
  - SORD
  - LOX
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - HESPERIDIN
---
